To Compare the Consumption of Sevoflurane and Desflurane in Low Flow Anaesthesia
Launched by RAJIV GANDHI CANCER INSTITUTE & RESEARCH CENTER, INDIA · Sep 17, 2024
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
OBJECTIVES
PRIMARY To compare the mac hour consumption of sevoflurane and desflurane anaesthetic agents under low flow (one litre/min) conditions To calculate the carbon footprint of sevoflurane and desflurane in the low-flow anaesthesia being used in this study
SECONDARY To test whether a significant generation of carbon monoxide occurs due to the interaction of sevoflurane/desflurane with soda lime in the closed circuit.
Methodology Two groups: 1) low-flow sevoflurane (LFS) 2) low- flow desflurane (LFD) Anaesthesia will be administered according to the recommendations of the ASA Enviro...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with American Society of Anesthesiologists grade (ASA) I \& II.
- • 2. Patients with age 20-65 years.
- Exclusion Criteria:
- • 1. Contraindications to inhalation agents.
- • 2. Liver dysfunction.
- • 3. Chronic alcoholism.
- • 4. Chronic smokers.
About Rajiv Gandhi Cancer Institute & Research Center, India
The Rajiv Gandhi Cancer Institute & Research Center (RGCI&RC) in India is a leading institution dedicated to the comprehensive care and advanced research in oncology. Renowned for its commitment to providing cutting-edge cancer treatment, RGCI&RC combines clinical excellence with innovative research initiatives aimed at improving patient outcomes. The institute boasts state-of-the-art facilities and a multidisciplinary team of experts who collaborate to conduct clinical trials, explore new therapies, and enhance the understanding of cancer. RGCI&RC's mission is to advance cancer care through rigorous scientific inquiry and compassionate patient management, positioning itself as a pivotal player in the global fight against cancer.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Delhi, , India
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported